Does genetic ablation or pharmacological blockade of dipeptidyl peptidase IV impact T cell-dependent immune responses?
These data indicate Selective inhibition of DPP-IV does not impair T dependent immune responses to antigenic challenge.
Physician discussions of cancer screening are important and effective even when, as in the case of mammography, screening rates are already high, or, as in the case of FOBT, rates have tended to remain low. The value of communication about screening should be taught and promoted to primary care physicians who serve as gatekeepers to screening.